Comparative Pharmacology
Head-to-head clinical analysis: DECADRON W XYLOCAINE versus RAVOCAINE AND NOVOCAIN W NEO COBEFRIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DECADRON W XYLOCAINE versus RAVOCAINE AND NOVOCAIN W NEO COBEFRIN.
DECADRON W/ XYLOCAINE vs RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dexamethasone is a corticosteroid that binds to glucocorticoid receptors, modulating gene expression to reduce inflammation and immune response. Lidocaine is a sodium channel blocker that stabilizes neuronal membranes, inhibiting nerve impulse initiation and conduction, producing local anesthesia.
Ravocaine (propoxycaine) and Novocain (procaine) are ester-type local anesthetics that block voltage-gated sodium channels, inhibiting nerve impulse conduction. Neo-Cobefrin (levonordefrin) is a vasoconstrictor that acts on alpha-adrenergic receptors, causing local vasoconstriction to prolong anesthesia.
Not a standard pre-mixed combination; individual components dosed separately. Dexamethasone: 0.5-9 mg/day oral/IV divided every 6-12h. Lidocaine: 1-5 mg/kg IV bolus (max 300 mg), then 1-4 mg/min IV infusion; or local infiltration up to 4.5 mg/kg (max 300 mg) with epinephrine.
Local infiltration or nerve block: 1-7 mL of 2% solution (20 mg/mL lidocaine equivalent) with epinephrine 1:100,000, maximum dose 7 mg/kg (actual lidocaine) or 500 mg per procedure, not to exceed 3.5 mg/kg plain or 7 mg/kg with epinephrine in adults.
None Documented
None Documented
Dexamethasone: 3-4 hours (short-acting steroid). Lidocaine: 1.5-2 hours (prolonged in heart failure/hepatic disease).
Procaine: 40–84 seconds (plasma ester hydrolysis); 2-(diethylamino)ethanol metabolite: 2–4 hours; Levonordefrin: ~2 hours
Dexamethasone: Renal (~65% as metabolites, <10% unchanged); Biliary/Fecal (<35%). Lidocaine: Hepatic metabolism to MEGX; Renal (<10% unchanged).
Renal excretion of metabolites (>90% as para-aminobenzoic acid and other conjugates); <10% unchanged
Category C
Category C
Corticosteroid/Local Anesthetic Combination
Local Anesthetic Combination